GlassScriptPhysician profile
Jamal Khan
NPI 1447646930
$18,301.57
in general payments reported to CMS, 2019-2025
46 companies · $5,546 in 2025
The $5,546 reported for 2025 was more than what 95% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $36.64 · 2021: $2,014 · 2022: $3,999 · 2023: $2,407 · 2024: $4,298 · 2025: $5,546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,383.48 |
| Travel and Lodging | $867.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,076.68 | 2022-2025 | Intracept, General - Pain Management, General - Balloons |
| Relievant Medsystems, INC. | $3,159.19 | 2021-2023 | Intracept |
| Nevro Corp. | $1,339.81 | 2020-2024 | Senza |
| Medtronic, INC. | $1,306.49 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Accurian |
| Mml US, INC. | $1,186.51 | 2022-2023 | Reactiv8 |
| Biotronik Nro, INC. | $886.81 | 2025 | Prospera |
| Abbvie INC. | $855.51 | 2022-2025 | |
| Spinal Simplicity, LLC | $854.95 | 2022-2023 | Ha Minuteman G3-R |
| Painteq LLC | $488.81 | 2021-2024 | Painteq |
| Globus Medical, INC. | $439.19 | 2025 | Senza |
| Collegium Pharmaceutical, INC. | $424.15 | 2021-2025 | Belbuca, Xtampza, Nucynta |
| Si-Bone, INC. | $383.32 | 2021-2025 | |
| Forte Bio-Pharma LLC | $320.91 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Saluda Medical Americas, INC. | $241.13 | 2023-2024 | Evoke, Evoke Scs |
| Abbott Laboratories | $241.09 | 2024-2025 | Proclaim, Eterna |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamal Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.